New facility will focus on crosslinkers and binders, with the potential to test tens of thousands of formulations per year. Digitalization and automation enable data...

Ineos Enterprises has completed the sale of its composites business to KPS Capital Partners, LP (“KPS”) for ~€1.7 billion.

The Seqens Group, a global manufacturer of health, personal care, and specialty ingredients, recently announced a strategic partnership with Novonesis, a sustainable...

US healthcare giant Johnson & Johnson (J&J) has unveiled plans to invest over $55 billion in the US over the next four years. This significant investment marks a 25%...

MSD (Merck & Co.) and Hengrui Pharma recently announced that they have entered into an exclusive license agreement for HRS-5346, an investigational oral small molecule...

JFE Steel, Mitsubishi Gas Chemical, and Mitsubishi Chemical collaborate to develop a carbon recycling supply chain at Mizushima Complex.

Britain’s AstraZeneca wants to invest $2.5 billion in Beijing, China to establish its sixth global strategic R&D center.

Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings...

Circular Economy is not just about sustainability – it’s a strategic advantage. Jan Haemer and James Hogan, Simon-Kucher & Partners, explain why.